Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema (right eye)
ICD-10 E10.3311 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema (right eye).
E10.3311 refers to a specific condition in which a patient has Type 1 diabetes mellitus accompanied by moderate nonproliferative diabetic retinopathy (NPDR) and macular edema in the right eye. Type 1 diabetes is characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Diabetic retinopathy is a common complication of diabetes, resulting from damage to the retinal blood vessels due to prolonged hyperglycemia. Moderate NPDR indicates that there are noticeable changes in the retina, such as microaneurysms and retinal hemorrhages, but without the severe complications seen in proliferative diabetic retinopathy. Macular edema, a condition where fluid accumulates in the macula, can lead to vision impairment. Management of this condition often involves strict glycemic control, regular eye examinations, and potentially treatments such as laser therapy or intravitreal injections to reduce edema and prevent further vision loss.
Detailed retinal examination findings, including the presence and extent of edema and retinopathy.
Patients presenting with vision changes, routine diabetic eye exams, and follow-up for diabetic retinopathy.
Ensure documentation includes specific findings related to the right eye and any treatments administered.
Comprehensive diabetes management plan, including insulin regimen and HbA1c levels.
Management of Type 1 diabetes, monitoring for complications, and adjustments in insulin therapy.
Document the patient's glycemic control and any referrals to ophthalmology for retinopathy management.
Used during routine eye exams for diabetic patients.
Document findings of the eye exam, including retinopathy assessment.
Ophthalmologists should ensure detailed documentation of diabetic retinopathy findings.
Specifying the eye affected is crucial for treatment planning and monitoring progression, as diabetic retinopathy can affect each eye differently.
